特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
268909

バイオインフォマティクス:技術と世界市場

Bioinformatics: Technologies and Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 231 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
バイオインフォマティクス:技術と世界市場
出版日: 2019年11月11日
発行: BCC Research
ページ情報: 英文 231 Pages
納期: 即納可能 即納可能とは
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオインフォマティクス市場は、2018年の75億米ドルから、2023年までに200億米ドルまで拡大すると見られています。市場は、2018年~2023年のCAGR (複合年間成長率) で、21.7%の成長が予測されています。

当レポートでは、世界のバイオインフォマティクス市場について調査分析し、市場概要、市場動向分析と予測、目標と役割、応用、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 世界のバイオインフォマティクス市場:概要

  • バイオインフォマティクスの目標
    • 生物学的データソース
    • システム生物学におけるバイオインフォマティクス
    • 精密医療
    • 薬剤開発におけるバイオインフォマティクス
    • ケモインフォマティクス
    • 次世代シークエンシング
    • メタゲノミクス
    • データ管理システム
  • 市場動向
    • 精密医療とバイオマーカーの同定
    • クラウドベースソリューション
    • 価値ベースのケアへの移行
  • 市場課題
    • データ統合
    • データの信頼性と標準化
    • エンドツーエンドのワークフロー
  • 現在の市場
    • 市場:地域別
    • 市場:カテゴリー別
    • 公的資金
    • 民間資金
    • 市場:用途別

第4章 バイオインフォマティクス:データ生成とデータ管理

  • 情報オーバーロード
    • データ量
    • データの多様性
    • データの速度
    • データの正確度
  • ソフトウェアの拡張性と有効性
  • ビッグデータ世代を支える技術
    • ゲノミクス
  • NGSソフトウェアツールの急増
    • 機能ゲノミクス
    • CRISPR Cas9 システム
  • プロテオミクスの進化
  • 糖鎖生物学の登場
  • RNAシークエンシング
  • メタボロミクスの進化
  • ケモインフォマティクスの進化
  • 新興技術
  • 薬理ゲノミクスの進化
  • iSAEC
  • 薬理ゲノミクスソフトウェア
  • トキシコゲノミクスの進化
  • トキシコゲノミクスのカスタマイズドプラットフォーム
  • データベース管理サービス
  • 市場力学

第5章 バイオインフォマティクス:データアナリティクスとソフトウェア

  • イントロダクション
  • データアナリティクスソフトウェア
  • バイオシミュレーションモデル
  • 市場分析

第6章 バイオインフォマティクス:データ処理とストレージ

  • ギャップへの配慮
  • 情報技術インフラ
  • 高性能コンピューティング
  • 高性能コンピュータークラスター
  • クラウドコンピューティング
    • DaaS
    • IaaS
    • PaaS
    • SaaS
    • SECaaS
  • クラウドコンピューティングの課題
  • クラウドコンピューティングの将来
  • 市場分析

第7章 バイオインフォマティクス:シークエンシングサービスとプラットフォーム

  • 市場分析
  • 市場セグメントの比較分析

第8章 バイオインフォマティクス:シークエンシングの応用

  • 市場分析

第9章 医薬品R&Dにおけるバイオインフォマティクスの応用

  • イントロダクション
  • 創薬と薬剤開発プロセス
  • 臨床研究:薬剤開発
  • 上市後の継続的研究・第IV相臨床試験
  • 結論

第10章 市場動向と分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スイス
  • アジア太平洋地域
    • インド
    • 中国
  • 結論

第11章 企業プロファイル

  • 3RD MILLENNIUM INC.
  • BIOMATTERS LTD. GENEIOUS
  • COMPUGEN LTD.
  • DASSAULT SYSTEMES BIOVIA
  • DNASTAR, INC.
  • GENEDATA AG
  • GENEVA BIOFORMATICS (GENEBIO) SA
  • GENOLOGICS LIFESCIENCES SOFTWARE INC.
  • GENOMATIX SOFTWARE GMBH
  • GNS HEALTHCARE INC.
  • GVK BIOSCIENCES PVT. LTD.
  • INTE LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
  • ILLUMINA INC.
  • MACVECTOR INC.
  • MOLECULAR CONNECTIONS PVT. LTD.
  • MOLECULAR NETWORKS GMBH
  • NONLINEAR DYNAMICS LTD.
  • OCIMUM BIOSOLUTIONS LTD.
  • PERKINELMER INFORMATICS INC.
  • PERSONALIS INC.
  • QLUCORE AB
  • REAL TIME GENOMICS INC.
  • SMARTGENE SERVICES SARL
  • STRAND LIFE SCIENCES
  • SYNGENE INTERNATIONAL
図表

List of Tables

  • Summary Table: Overall Global Bioinformatics Market, by Region, Through 2023
    • Table 1: Investments in Microbiology
    • Table 2: PDB Data Distribution, by Experimental Method and Molecular Type, 2017
    • Table 3: RefSeq Accession Growth, 2016 and 2018
    • Table 4: Sequencing Services and Platforms as Available in EBI Database
    • Table 5: Recommendations for NGS Bioinformatics Tools
    • Table 6: Leading Institutional Developers of Bioinformatics Tools, 2017
    • Table 7: Bioinformatics Tools Used for Metagenomics Analysis
    • Table 8: DBMS Platforms in Bioinformatics
    • Table 9: Growth in Selected EMBL-EBI Resources, 2015-2016
    • Table 10: Number of FDA and EMA Drug Approvals, 2012-2016
    • Table 11: Global Bioinformatics Market, by Region, Through 2023
    • Table 12: Public Funding Programs, 2012-2018
    • Table 13: Global Bioinformatics Market, by Category, Through 2023
    • Table 14: Global Bioinformatics Market, by Application, Through 2023
    • Table 15: Cloud-Based Bioinformatics Tools
    • Table 16: Commercially Available Metabolomics Software
    • Table 17: Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
    • Table 18: Cheminformatics Software Solutions for Drug R&D
    • Table 19: Bioinformatic Tools for Metagenomic Studies
    • Table 20: Pharmacogenomic Biomarkers in Drug Labeling
    • Table 21: Recent Research on Biomarkers
    • Table 22: Bioinformatic Tools and Databases Used in Pharmacogenomics
    • Table 23: Bioinformatic Tools for Pharmacogenomic Studies
    • Table 24: Bioinformatic Tools for Pharmacogenomic Software
    • Table 25: Toxicogenomic Studies Planned or Ongoing, 2016
    • Table 26: Bioinformatics Archival Databases
    • Table 27: Bioinformatics Curative Databases
    • Table 28: Commercially Available Bioinformatics Databases
    • Table 29: Biological Databases for Human Research
    • Table 30: Software for Biological Analysis
    • Table 31: Open Source Bioinformatics Software
    • Table 32: NGS Platforms for Clinical Diagnostics
    • Table 33: Commonly Used Tools for NGS-based DNA Analysis, by Functional Category
    • Table 34: Commercially Available Integrated DNA Analysis Solutions and Relevant Functionality
    • Table 35: High-Performance Computing Architectures: Advantages and Drawbacks
    • Table 36: Highest Performance Supercomputers, 2018
    • Table 37: SaaS Products
    • Table 38: Global Bioinformatics Market, by Sequencing Services and Platforms, Through 2023
    • Table 39: Sequence Analysis Software
    • Table 40: Sequence Alignment Platforms
    • Table 41: Global Bioinformatics Market, by Sequencing Application, Through 2023
    • Table 42: Sequencing Data Analysis Bioinformatics Software and Tools
    • Table 43: Bioinformatics-Based Clinical and Medical Laboratory Information Management System
    • Table 44: Number of Therapeutic Drugs Developed Globally, by Disease Category, 2017
    • Table 45: Bioinformatics Databases
    • Table 46: Leading Drug Target Databases
    • Table 47: Computer Simulation Platforms
    • Table 48: Application of Cloud-Based Services in Healthcare
    • Table 49: Leading LIMS Providers
    • Table 50: Key Suppliers of ELNs
    • Table 51: Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
    • Table 52: Drug R&D Process Overview
    • Table 53: Leading EHR Providers, 2018
    • Table 54: Medical Applications for Healthcare Professionals
    • Table 55: Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2017
    • Table 56: North American Bioinformatics Market, by Country, Through 2023
    • Table 57: Leading Bioinformatics Companies in the U.S.
    • Table 58: Venture Capital Companies Most Active in the Biotech Sector, 2015
    • Table 59: U.S. Bioinformatics Market, by Application, Through 2023
    • Table 60: U.S. Bioinformatics Market, by Category, Through 2023
    • Table 61: Canadian Bioinformatics Market, by Category, Through 2023
    • Table 62: Leading Canadian Bioinformatics Companies
    • Table 63: Canadian Bioinformatic Market, by Application, Through 2023
    • Table 64: European Bioinformatics Market, by Country, Through 2023
    • Table 65: Leading European Bioinformatics Companies
    • Table 66: U.K. Bioinformatics Market, by Category, Through 2023
    • Table 67: U.K. Bioinformatics Market, by Application, Through 2023
    • Table 68: German Bioinformatics Market, by Category, Through 2023
    • Table 69: German Bioinformatics Market, by Application, Through 2023
    • Table 70: Swiss Bioinformatics Market, by Category, Through 2023
    • Table 71: Swiss Bioinformatics Market, by Application, Through 2023
    • Table 72: Asia-Pacific Bioinformatics Market, by Country, Through 2023
    • Table 73: Indian Bioinformatics Market, by Category, Through 2023
    • Table 74: Leading Indian Bioinformatics Companies
    • Table 75: Indian Bioinformatics Market, by Application, Through 2023
    • Table 76: Chinese Bioinformatics Market, by Category, Through 2023
    • Table 77: Chinese Bioinformatics Market, by Application, Through 2023
    • Table 78: Biomatters Ltd.: Product Portfolio
    • Table 79: Compugen Ltd.: Product Portfolio
    • Table 80: Dassault Systemes Biovia: Product Portfolio
    • Table 81: DNASTAR Inc.: Product Portfolio
    • Table 82: DNASTAR Inc.: Recent Developments, 2016
    • Table 83: Genedata AG: Product Portfolio
    • Table 84: Genedata AG: Recent Developments, 2017
    • Table 85: Geneva Bioformatics (GeneBio) SA: Product Portfolio
    • Table 86: Genologics Lifesciences Software Inc.: Product Portfolio
    • Table 87: Genomatix Software GmbH: Product Portfolio
    • Table 88: GNS Healthcare Inc.: Product Portfolio
    • Table 89: GNS Healthcare Inc.: Recent Developments, 2015-2017
    • Table 90: GVK Biosciences Pvt. Ltd.: Product Portfolio
    • Table 91: GVK Biosciences Pvt. Ltd: Recent Developments, 2017
    • Table 92: Inte: Ligand Software Entwicklungs Und Consulting GmbH: Product Portfolio
    • Table 93: Illumina Inc.: Product Portfolio
    • Table 94: Illumina Inc.: Recent Developments, 2016-2017
    • Table 95: MacVector Inc.: Product Portfolio
    • Table 96: Molecular Connections Pvt. Ltd.: Product Portfolio
    • Table 97: Molecular Networks GmbH: Product Portfolio
    • Table 98: Nonlinear Dynamics Ltd.: Product Portfolio
    • Table 99: Ocimum Biosolutions Ltd.: Product Portfolio
    • Table 100: PerkinElmer Informatics Inc.: Product Portfolio
    • Table 101: Qlucore AB: Product Portfolio
    • Table 102: Qlucore AB: Product Portfolio
    • Table 103: Qlucore AB: Recent Developments, 2018
    • Table 104: Real Time Genomics Inc.: Product Portfolio
    • Table 105: Real Time Genomics Inc.: Recent Developments, 2016
    • Table 106: Smartgene Services SARL: Product Portfolio
    • Table 107: Strand Life Sciences: Product Portfolio
    • Table 108: Strand Life Sciences: Recent Developments, 2017 and 2018
    • Table 109: Syngene International: Product Portfolio
    • Table 110: Syngene International: Recent Developments, 2016-2019

List of Figures

  • Summary Figure: Overall Global Bioinformatics Market, by Region, 2017-2023
    • Figure 1: PDB Data Distribution, by Experimental Method and Molecular Type, 2017
    • Figure 2: RefSeq Accession Growth, 2016 and 2018
    • Figure 3: Relationship of Bioinformatics with Omic Technologies
    • Figure 4: Schematic Representation of Biology Systems and Translational Bioinformatics
    • Figure 5: Principles of Precision Medicine
    • Figure 6: Applications of Bioinformatics in Drug Development
    • Figure 7: Collaboration within the Bioinformatics Arena, by Country, Since 2016
    • Figure 8: Number of Drug Approvals, by FDA's CDER, 2008-2018*
    • Figure 9: Number of CDER's Annual Novel Drug Approvals, 2009-2018
    • Figure 10: The Four Dimensions of Big Data
    • Figure 11: Software Scalability of Big Data Bioinformatics
    • Figure 12: Software Validation of Big Data Bioinformatics
    • Figure 13: Percentage Distribution of Breast Cancer Diagnosis Among the U.S. Women, by Age Group, 2017
    • Figure 14: Top-Down Proteomic Approach
    • Figure 15: European Bioinformatics Institute Software Solutions
    • Figure 16: Evolution of Information Technology Infrastructure
    • Figure 17: Schematic Representation of Cloud Computing Services
    • Figure 18: Global Bioinformatics Market Share, by Sequencing Services and Platforms, 2017 and 2023
    • Figure 19: Global Bioinformatics Market, by Sequencing Services, 2017-2023
    • Figure 20: Global Bioinformatics Market, by Sequencing Platform, 2017-2023
    • Figure 21: Clinical Bioinformatics for Patients for Precision Health
    • Figure 22: Number of Therapeutic Drugs Developed Globally, by Disease Category, 2017
    • Figure 23: Classical and Digital Forensics with Respect to Bioinformatics
    • Figure 24: Drug Development Process
    • Figure 25: Phases in the Drug Discovery and Development Process
    • Figure 26: Phase Transition Success Rates and Likelihood of Approvals for All Modalities and Medicines, 2017
    • Figure 27: Steps in Drug Discovery
    • Figure 28: Information Systems within the Laboratory Architecture
    • Figure 29: Application of Bioinformatics in Clinical Trials
    • Figure 30: Key Areas of Research Utilizing Bioinformatics
目次
Product Code: BIO051E

Report Highlights:

The global bioinformatics market should grow from $7.5 billion in 2018 to $20.0 billion by 2023, with a compound annual growth rate (CAGR) of 21.7% during the period of 2018-2023.

The North American regional bioinformatics market should grow from $4.1 billion in 2018 to $11.4 billion by 2023, with a CAGR of 22.7% during the period of 2018-2023.

The Asia-Pacific regional bioinformatics market should grow from $1.7 billion in 2018 to $4.6 billion by 2023, with a CAGR of 22.0% during the period of 2018-2023.

Report Scope:

The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.

Report Includes:

  • 31 data tables and 80 additional tables
  • Comprehensive details of the global bioinformatics market and relevant technologies
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of the market trends and analysis regarding industry service providers and software solution developers, as well as information technology (IT) and bioinformatics service providers that support the pharma and biotech industries
  • Review of challenges and opportunities underlying in the bioinformatics market following the adoption of high-throughput technologies such as next-generation sequencing (NGS), the analysis of big data, and the emergence of cloud-based solutions
  • Insight into the sequencing and pharmaceutical R&D applications of bioinformatics in drug development and clinical trials, including cheminformatics, next-generation sequencing, metagenomics and data management systems
  • A look at the investigational new drug applications, NDA approvals, leading EHRs providers, mobile health technologies, and recent partnerships and agreements in the pharmaceutical and bioinformatic sectors
  • Profile description of key pharmaceutical and biotechnology companies, including Dassault Systemes Biovia, Genedata AG, PerkinElmer Informatics Inc., Qlucore AB and Syngene International

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Global Bioinformatics Market: Overview

  • Goal of Bioinformatics
    • Biological Data Sources
    • Bioinformatics in Systems Biology
    • Precision Medicine
    • Bioinformatics in Drug Development
    • Cheminformatics
    • Next-Generation Sequencing
    • Metagenomics
    • Database Management Systems
  • Market Trends
    • Precision Medicine and Biomarker Identification
    • Cloud-Based Solutions
    • Shift Toward Value-Based Care
  • Market Challenges
    • Data Integration
    • Data Reliability and Standardization
    • End-to-End Workflows
  • Current Market
    • Market by Region
    • Market by Category
    • Public Funding
    • Private Funding
    • Market by Application

Chapter 4: Bioinformatics: Data Generation and Data Management

  • Information Overload
    • Data Volume
    • Data Variety
    • Data Velocity
    • Data Veracity
  • Software Scalability and Validity
  • Technologies Behind Big Data Generation
    • Genomics
  • Exponential Growth in NGS Software Tools
    • Functional Genomics
    • CRISPR Cas9 System
  • Proteomic Advances
    • Qualitative Proteomics
    • Quantitative Proteomics
    • Structural Proteomics
    • Advances in MS-Based Proteomics Technology for Exploring Triple Negative Breast Cancer
    • Sample Preparation Assays
    • Tagging/Affinity Methods
    • Utility of Proteomics to Identify Biomarkers
    • Investments in Structural Genomics and Open Science
    • Interaction Proteomics
    • Applications in Drug Discovery
    • Bottom-Up vs. Top-Down Proteomics
  • Emergence of Glycomics
    • Human Proteome Organization and Human Proteome Project Initiatives
    • Transcriptomic Advances
  • RNA Sequencing
    • Co-Expression and Single-Cell RNA-Seq
  • Metabolomic Advances
  • Advances in Cheminformatics
  • Emerging Technologies
    • Metagenomic Advances
    • Epigenomic Advances
  • Pharmacogenomic Advances
    • Pharmacogenomics and Precision Medicine
    • Value-Based Decisions
    • Pharmacogenomics and R&D
  • International Serious Adverse Events Consortium
  • Pharmacogenomic Software
  • Toxicogenomic Advances
  • Customized Toxicogenomic Platforms
  • Database Management Services
  • Market Dynamics

Chapter 5: Bioinformatics: Data Analysis and Software

  • Introduction
  • Data Analysis Software
  • Biosimulation Models
  • Market Analysis

Chapter 6: Bioinformatics: Data Processing and Storage

  • Mind the Gap
  • Information Technology Infrastructure
  • High-Performance Computing
  • High-Performance Computer Clusters
  • Cloud Computing
    • Data as a Service
    • Infrastructure as a Service
    • Platform as a Service
    • Software as a Service
    • Security as a Service
  • Cloud Computing Challenges
  • Future of Cloud Computing
  • Market Analysis

Chapter 7: Bioinformatics: Sequencing Services and Platforms

  • Market Analysis
  • Comparative Analysis Across Market Segments, 2017 and 2023
    • Sequencing Services
    • Sequencing Platforms
    • Sequence Analysis Platforms
    • Sequence Alignment Platforms
    • Sequence Manipulation Platforms

Chapter 8: Bioinformatics: Sequencing Applications

  • Market Analysis
    • Agrigenomics
    • Clinical and Medical
    • Genealogy
    • Other Fields

Chapter 9: Bioinformatic Applications in Pharmaceutical R&D

  • Introduction
  • Drug Discovery and Development Process
    • Target Identification
    • Target Validation
    • Lead Identification
    • Lead Optimization
  • Clinical Research: Drug Development
    • Preclinical Experiments
    • Investigational New Drug Applications
    • Clinical Trials
    • New Drug Application
    • NDA Approval
  • Post-Launch Ongoing Studies and Phase IV Clinical Trials
    • Electronic Health Records
    • Mobile Health Technologies
    • Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
  • Conclusions

Chapter 10: Market Trends and Analysis

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • Switzerland
  • Asia-Pacific
    • India
    • China
  • Conclusions

Chapter 11: Company Profiles

  • 3RD MILLENNIUM INC.
  • BIOMATTERS LTD. GENEIOUS
  • COMPUGEN LTD.
  • DASSAULT SYSTEMES BIOVIA
  • DNASTAR, INC.
  • GENEDATA AG
  • GENEVA BIOFORMATICS (GENEBIO) SA
  • GENOLOGICS LIFESCIENCES SOFTWARE INC.
  • GENOMATIX SOFTWARE GMBH
  • GNS HEALTHCARE INC.
  • GVK BIOSCIENCES PVT. LTD.
  • INTE LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
  • ILLUMINA INC.
  • MACVECTOR INC.
  • MOLECULAR CONNECTIONS PVT. LTD.
  • MOLECULAR NETWORKS GMBH
  • NONLINEAR DYNAMICS LTD.
  • OCIMUM BIOSOLUTIONS LTD.
  • PERKINELMER INFORMATICS INC.
  • PERSONALIS INC.
  • QLUCORE AB
  • REAL TIME GENOMICS INC.
  • SMARTGENE SERVICES SARL
  • STRAND LIFE SCIENCES
  • SYNGENE INTERNATIONAL
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.